Market and company headlines
Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 10.53 percent increase over losses of $(0.19) per
Benzinga·12:39·2 Months AgoBDTX▲+0.6%